Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Prz Gastroenterol ; 19(2): 135-142, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38939071

RESUMO

Introduction: The eradication rate of Helicobacter pylori (H. pylori) has decreased due to antibiotics resistance and inadequate acid suppression. Vonoprazan is a novel potassium-competitive acid blocker (P-CAB), which has a rapid and sustained acid inhibitory effect and may be more effective than conventional proton pump inhibitors (PPIs) in H. pylori eradication. Aim: to study the efficacy and safety of vonoprazan as a component of first-line H. pylori eradication treatment compared with conventional PPI-based therapy. Material and methods: This randomised (one to one) non-blinded study was conducted on 400 consecutive proven H. pylori infected patients, of whom 200 received vonoprazan-based triple therapy, while 200 patients received PPI-based triple therapy for 14 days. The study outcomes were evaluated as eradication rate and adverse events in both patient groups. Results: The eradication rate was 86% in the vonoprazan group and 74.5% in the PPI group. The vonoprazan eradication rate was significantly higher than that of PPIs (p = 0.004). There was no significant difference regarding adverse events between both patient groups. Conclusions: Vonoprazan-based therapy was more effective than PPI-based therapy as a first-line H. pylori eradication treatment. Vonoprazan was generally safe and well tolerated.

2.
Clin Exp Hepatol ; 10(1): 14-19, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38765908

RESUMO

Managing patients with liver cirrhosis and gastric hyperplastic polyps (GHPs) is challenging. Despite being the standard technique for resection of GHPs, hot snare polypectomy (HSP) is risky in the setting of coagulation disorders associated with liver cirrhosis. The aim of the study was to assess the efficacy and safety of endoscopic band ligation (EBL), compared to HSP in resecting GHPs in cirrhotic patients. One hundred consecutive adults with liver cirrhosis and sessile or pedunculated GHPs were enrolled from December 2018 to December 2020. Cases were non-blindly randomized (1 : 1) to two groups to have GHPs managed by either EBL (group I) or HSP (group II). Data of demographic, clinical, and pathological factors, hospitalization expenses and outcomes of both treatment maneuvers were collected and statistically analyzed. Upper endoscopy was repeated for all patients at 3, 6 and 12 months after treatment for recurrence detection. Between the two procedures, the mean operational time was significantly shorter in the EBL than the HSP group (15.1 ±3.80 min vs. 36.6 ±6.72 min, p < 0.001). Concerning complications, 94% of EBL cases had reported no complications compared to 78% with HSP. Bleeding occurred only with HSP (20%) with urgent need for adrenaline and/or argon plasma coagulation (p = 0.003). Regarding cost, it was significantly lower in EBL than HSP (280 ±2.02 EGP vs. 390 ±181.8 EGP, p < 0.001). However, the recurrence rate of GHPs and number of needed sessions were not significantly different. EBL proved to be a safer, more rapid, and economic maneuver when compared to HSP on resecting GHPs in patients with liver cirrhosis.

3.
BMC Infect Dis ; 24(1): 408, 2024 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-38627630

RESUMO

BACKGROUND: Toxoplasma gondii (T. gondii) and Helicobacter pylori (H. pylori) are among the most prevalent foodborne parasitic and bacterial infections worldwide. However, the concurrent impact of coinfection on gastric pathology has yet to be studied in depth. The effect of coinfection generally either adds a synergetic or antagonistic impact; we aimed in the current work to assess the impact of T. gondii coinfection on the progression of H. pylori-associated gastric pathology and reporting H. pylori virulent strains. The study was conducted on 82 patients complaining of persistent gastrointestinal symptoms with failed treatment response and prone to endoscopy. They were subjected to stool examination to detect H. pylori antigen, serological screening for latent toxoplasmosis, endoscopy, histopathological examination, and molecular detection of H. pylori virulence strains in gastric biopsies. Out of the 82 patients, 62 patients were positive for H. pylori antigen in stool and 55 patients confirmed positivity by histopathology; out of them, 37 patients had isolated Vac As1 variants, 11 patients had combined Vac As1 and Cag A variants, and 7 patients had combined Vac As1, Cag A and VacAs2 variants. Patients with the combined two or three variances showed significantly deteriorated histopathological features than patients with a single Vac As1 variant (P < 0.05). Latent toxoplasmosis was positive among 35/82 patients. Combined H. pylori and Toxoplasma gondii infection had significantly marked inflammation than patients with isolated infection (P < 0.05). CONCLUSION: Screening for toxoplasmosis among H. pylori-infected patients is recommended as it is considered a potential risk factor for gastric inflammation severity. H. pylori gastric inflammation may be heightened by Toxoplasma coinfection.


Assuntos
Coinfecção , Gastrite , Infecções por Helicobacter , Helicobacter pylori , Toxoplasma , Toxoplasmose , Humanos , Antígenos de Bactérias , Gastrite/microbiologia , Toxoplasmose/complicações , Infecções por Helicobacter/microbiologia , Inflamação
4.
Int J Surg Case Rep ; 106: 108259, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37148724

RESUMO

INTRODUCTION AND IMPORTANCE: Colorectal cancer rarely metastasizes to the bones, and if so, metastasis usually occurs in the axial skeleton. We encountered a rare case of a metastatic lesion to the right ulna arising from colonic adenocarcinoma that was treated by resection of the proximal ulna and radial neck-to-humerus trochlea transposition to salvage the limb. CASE PRESENTATION: A 60-year-old man previously diagnosed with colonic adenocarcinoma presented with a single bony metastatic lesion in the right proximal ulna and was referred to our clinic for assessment. After five sessions of systemic therapy, the lesion continued to grow, causing diffuse swelling and loss of elbow range of motion. Local x-rays revealed extensive destruction of the proximal ulna and soft tissue component, with subluxation of the radial head. Magnetic resonance imaging showed an extensive lesion involving the proximal half of the ulna and a large soft tissue component. After restaging, only this metastatic lesion was found. Amputation was offered to the patient for wide margin resection, but the patient refused; therefore, we performed resection of the proximal ulna, debulking of soft tissue, and radial neck-to-humerus trochlea transposition to salvage the limb. CLINICAL DISCUSSION: Due to the rarity of the location, no clinical standard exists regarding the surgical treatment. Radial neck-to-humerus trochlea transposition is a valid surgical reconstruction technique to salvage the limb and preserve the hand function. CONCLUSION: Radial neck-to-humerus trochlea transposition is an alternative elbow reconstruction technique after proximal ulna resection in cases where other options are not ideal or contraindicated. Long-term studies are recommended to assess different surgical options for treating and reconstructing proximal ulnar tumors.

5.
Egypt Liver J ; 12(1): 5, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35036011

RESUMO

BACKGROUND: Lately, the humanity has been being threatened by the coronavirus disease (COVID-19). The virus-related destructive motives can damage not only the lungs but also the brain, blood vessels, kidneys, and the heart. CASE PRESENTATION: A middle-aged female presented with jaundice post-COVID-19 pneumonia. The patient had past history of cholecystectomy 20 years ago. Both laboratory and imaging data revealed a picture of cholestasis with right lobe liver abscess. Despite drainage and culture-based antibiotics, no improvement ensued. Endoscopic retrograde cholangiopancreatography was done revealing mildly dilated common bile duct (CBD), multiple large stones, mildly dilated central biliary radicals, and an old overlooked stent inside the dilated CBD. Papillotomy and papilloplasty were undertaken followed by stones' extraction with insertion of 2 plastic stents (10 cm× 10 f), and a flow of thick dark bile was inspected. The patient was finally improved and safely discharged. CONCLUSION: Herein, we present the first case of long-retained quiescent biliary stent which was over-headed by a cholangitic abscess in the vicinity of COVID pneumonia.

6.
Eur J Gastroenterol Hepatol ; 28(7): 777-85, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27097354

RESUMO

BACKGROUND: Spontaneous bacterial peritonitis (SBP) is a major risk factor for hepatorenal syndrome. Albumin infusion has been shown to prevent renal impairment and reduce mortality in SBP. The study aimed to compare the effect of different therapeutic modalities on hemodynamics and short clinical outcomes in high-risk patients with SBP. METHODS: Two hundred cirrhotic patients with SBP and bilirubin greater than 4 mg[Fraction Slash]dl or creatinine more than 1 mg[Fraction Slash]dl were enrolled. Patients were randomized to receive albumin, terlipressin, low-dose albumin plus terlipressin, or midodrine. Systemic, renal, and hepatic hemodynamics were estimated at baseline, 3, and 10 days of treatment. Renal impairment was diagnosed when the blood urea nitrogen or serum creatinine levels increased by more than 50% of the pretreatment value. RESULTS: SBP resolved in most of patients in all groups (P>0.05). Cardiac output and portal flow decreased, whereas systemic vascular resistance increased significantly in terlipressin and albumin plus terlipressin groups compared with the albumin group after 3 and 10 days. After 10 days, plasma renin activity, renal, and hepatic arteries resistive index were significantly higher in the midodrine group compared with the albumin group. The midodrine group did not show any significant changes in the heart rate, mean arterial pressure, cardiac output, and portal blood flow compared with the albumin group after 3 or 10 days. There was no significant difference in renal impairment or mortality between any of the groups. CONCLUSION: Terlipressin and low-dose albumin plus terlipressin could be used as a therapeutic alternative to standard-dose albumin in high-risk SBP patients.


Assuntos
Infecções Bacterianas/complicações , Síndrome Hepatorrenal/prevenção & controle , Circulação Hepática/efeitos dos fármacos , Cirrose Hepática/complicações , Peritonite/complicações , Circulação Renal/efeitos dos fármacos , Adulto , Infecções Bacterianas/fisiopatologia , Quimioterapia Combinada , Feminino , Hemodinâmica/efeitos dos fármacos , Síndrome Hepatorrenal/etiologia , Humanos , Cirrose Hepática/fisiopatologia , Lipressina/análogos & derivados , Lipressina/uso terapêutico , Masculino , Pessoa de Meia-Idade , Midodrina/uso terapêutico , Peritonite/fisiopatologia , Albumina Sérica/uso terapêutico , Terlipressina , Resultado do Tratamento , Vasoconstritores/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...